Specif

Journal of Biomedical Optics

Volumn 19, Issue 10, 2014, Pages

  Maawy, Ali A ^a   Hiroshima, Yukihiko ^a,b,c   Zhang, Yong ^b   Luiken, George A ^d   Hoffman, Robert M ^a,b   Bouvet, Michael ^a,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ANTICANCER INC   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d OncoFluor Inc   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

antibody; chimeric anti carcinoembryonic antigen; imaging; near infrared dyes; nude mice; pancreatic cancer; polyethylene glycol linkage; polyethylene glycol linkage.

Indexed keywords

ANTIBODIES; ANTIGENS; BODY FLUIDS; DISEASES; IMAGING TECHNIQUES; INFRARED DEVICES; MAMMALS; POLYETHYLENE GLYCOLS;

DYE CONCENTRATION; ELIMINATION KINETICS; METASTATIC TUMORS; NEAR-INFRARED DYES; NUDE MICE; PANCREATIC CANCERS; PANCREATIC TUMORS; SERUM CONCENTRATION;

TUMORS;

CARCINOEMBRYONIC ANTIGEN; CROSS LINKING REAGENT; DIAGNOSTIC AGENT; DRUG CARRIER; FLUORESCENT DYE; HYBRID PROTEIN; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CHEMISTRY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOLOGY; INFRARED RADIATION; METHODOLOGY; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STAINING; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FLUORESCENT DYES; HUMANS; INFRARED RAYS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; PANCREATIC NEOPLASMS; POLYETHYLENE GLYCOLS; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 84902097110     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.10.101504     Document Type: Article

References (26)

1. A. A. Maawy et al., "Comparison of a chimeric anti-carcinoembryonic antigen antibody conjugated with visible or near-infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude mouse models," J. Biomed. Opt. 18(12), 126016 (2013).
2. J. Kopecek, "Polymer-drug conjugates: origins, progress to date and future directions," Adv. Drug Deliv. Rev. 65(1), 49-59 (2013).
3. "Final report on the safety assessment of polyethylene glycols (PEGs)-6,-8,-32,-75,-150,-14M,-20M," Int. J. Toxicol. 12(5), 429-457 (1993).
4. C. Ozdemir and A. Güner, "Solubility profiles of poly(ethylene glycol)/ solvent systems, I: qualitative comparison of solubility parameter approaches," Eur. Polym. J. 43(7), 3068-3093 (2007). (Pubitemid 47017229)
5. S. Dreborg and E. B. Akerblom, "Immunotherapy with monomethoxypolyethylene glycol modified allergens," Crit. Rev. Ther. Drug Carrier Syst. 6(4), 315-365 (1990). (Pubitemid 20216395)
6. A. P. Chapman, "PEGylated antibodies and antibody fragments for improved therapy: a review," Adv. Drug Deliv. Rev. 54(4), 531-545 (2002). (Pubitemid 34615547)
7. T. Yamaoka, Y. Tabata, and Y. Ikada, "Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration," J. Pharm. Pharmacol. 47(6), 479-486 (1995).
8. K. Yamauchi et al., "Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable- magnification whole-mouse imaging system," Cancer Res. 66(8), 4208-4214 (2006).
9. L. Brunton, J. Lazo, and K. Parker, Goodman and Gilmans. The Pharmacological Basis of Therapeutics, McGraw-Hill, New York (2008).
10. K. Connors, Chemical Kinetics, The Study of Reaction Rates in Solution, VCH Publishers, New York (1991).
11. M. Bouvet and R. M. Hoffman, "Glowing tumors make for better detection and resection," Sci. Transl. Med. 3(110), 110-110 (2011).
12. Y. Hiroshima et al., "Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system," J. Laparoendosc. Adv. Surg. Tech. A 24(4), 241-247 (2014).
13. Y. Hiroshima et al., "Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice," J. Surg. Res. 187(2), 510-517 (2014).
14. S. Kaushal et al., "Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer," J. Gastrointest. Surg. 12(11), 1938-1950 (2008).
15. M. McElroy et al., "Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation," World J. Surg. 32(6), 1057-1066 (2008).
16. C. A. Metildi, R. M. Hoffman, and M. Bouvet, "Fluorescence-guided surgery and fluorescence laparoscopy for gastrointestinal cancers in clinically-relevant mouse models," Gastroenterol. Res. Pract. 2013, 290634 (2013).
17. C. A. Metildi et al., "Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models," J. Am. Coll. Surg. 215(1), 126-135; discussion 135-126 (2012).
18. C. A. Metildi et al., "An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models," J. Am. Coll. Surg. 214(6), 997-1007 e1002 (2012).
19. C. A. Metildi et al., "Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patientderived orthotopic xenograft (PDOX) nude mouse model," J. Surg. Oncol. 109(5), 451-458 (2014).
20. C. A. Metildi et al., "Fluorescence-guided surgery with a fluorophoreconjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer," Ann. Surg. Oncol. 21(4), 1405-1411 (2014).
21. C. A. Metildi et al., "Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model," J. Surg. Res. 179(1), 87-93 (2013).
22. C. A. Metildi et al., "In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody," Ann. Surg. Oncol. 20(Suppl 3), S693-S700 (2013).
23. H. S. Tran Cao et al., "Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer," Hepatogastroenterology 59(118), 1994-1999 (2012).
24. H. Kishimoto et al., "Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection," Cell Cycle 10(16), 2737-2741 (2011).
25. H. Kishimoto et al., "Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase- dependent adenoviruses," Mol. Cancer Ther. 8(11), 3001-3008 (2009).
26. H. Kishimoto et al., "In vivo internal tumor illumination by telomerasedependent adenoviral GFP for precise surgical navigation," Proc. Natl. Acad. Sci. U. S. A. 106(34), 14514-14517 (2009).